NCT06548854
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Dose Exploration Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Characteristics of STC314 Injection Administered Intravenously in Sepsis Patients
Phase: Phase 2
Role: Lead Sponsor
Start: Nov 20, 2023
Completion: Feb 28, 2025